Pfizer's Lipset assesses use of social media in trials; Data privacy scares continue to rock U.K.;

> Pfizer's ($PFE) Craig Lipset has looked at the risks and benefits of clinical trial participants using social media. Opinion

> A series of data privacy scares has hampered efforts to rebuild trust in the English database of patient records. News

> Worldwide Clinical Trials has picked BioClinica as its CTMS provider. Release

> SAP has released its attempt to accelerate the processing and analysis of genomics data. Item

> The former director of the Virginia Bioinformatics Institute is suing senior administrators over his demotion. News

> Dell ($DELL) and Intel ($INTC) are searching for startups with mobile technologies that improve patient outcomes. Post